Research to Prevent Blindness

RPB Catalyst award for innovative Research approaches for age-related macular degeneration

Contact Us

If you have any questions regarding the RPB Grants Program, please contact RPB's Grants Administrator, Pattie Moran, at 646-892-9566 or

Research to Prevent Blindness (RPB) is partnering with:

  • American Macular Degeneration Foundation (AMDF);
  • Dr. H. James and Carole Free;
  • International Retinal Research Foundation (IRRF);

to co-fund up to four Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration (AMD).  Two awards will be with AMDF, one award with Dr. H. James and Carole Free, and one award with IRRF.  The Catalyst Award provides funds to researchers who are working on novel approaches to AMD.  These Awards are intended to provide seed money to proposed high-risk/high-gain vision science research, which is innovative, cutting-edge, and demonstrates out-of-the-box thinking.  Research related to both dry and wet forms of AMD may be supported by this award.  The $300,000 grant is payable for up to three (3) years upon approval of a 14-month substantive progress report.

This award is available to researchers from any U.S. academic medical center.   Full-time department Chairs can nominate one candidate holding a primary academic position as Assistant Professor through full Professor.  Awardees are required to expend the award within three (3) years if granted the full $300,000. Otherwise, the awardee is required to expend the initial $150,000 within two (2) years.

The spring cycle application deadline for the Catalyst Award is January 20, with nomination forms due no later than December 15.  Applications received without a prior nomination form will not be accepted.  This award is not available during the fall cycle.  (If January 20 falls on a weekend or a holiday, consider the following business day the deadline.)  Contact Pattie Moran to obtain the Catalyst Award forms.

Download the Catalyst award Guidelines


Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.